---
{"dg-publish":true,"permalink":"/jethro-s-working-notes/pth-and-pt-hr-p-analogue/","dgPassFrontmatter":true}
---


# PTH and PTHrP Analogue

Created: November 22, 2022 3:59 PM
Tags: MSS, Medicine, Pharmacology
Updated: November 22, 2022 4:11 PM

### PTH and PTHrP Analogue

PTH and PTHrP analogue can be used in the [[Jethro’s Working Notes/Treatment of osteoporosis\|Treatment of osteoporosis]], but with limited clinical use due to its severe adverse effect.

- ********************************************************Examples of PTH and PTHrP analogue********************************************************
    
    Teriparatide, Abaloparatide
    
- ********MOA of PTH and PTHrP analogue********
    
    PTH and PTHrP analogues are bind to parathyroid hormone receptors, which results in increased bone formation.
    
    This results in increased bone mineral density.
    
- **********************************************************************************Adverse effects of PTH and PTHrP analogue**********************************************************************************
    - Hypercalcemia (due to stimulation of PTH receptors in the GI tract and kidneys)
    - Injection site reaction
    - Nausea
    - Leg cramps
    - ****************************Increased risk of osteosarcoma****************************
        
        Hence, PTH and PTHrP therapy is limited to less than 2 years, and only used when refractory to [[Jethro’s Working Notes/Bisphosphonate\|Bisphosphonate]] therapy.
        
- **********************************************************************Contraindications of PTHrP analogue**********************************************************************
    
    PTH and PTHrP analogue are contraindicated when there are increased risk of development of osteosarcoma:
    
    - Children with open epiphyses
    - Previous radiation of skeleton
    - Bone metastases
    - Elevation of serum alkaline phosphatase of skeletal origin